Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.

D Symmons; AJ. Silman

Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Arthritis Rheum
Volume	50( 6)
Publication status	Published - Jun 2004

Keywords

adverse effects: Antirheumatic Agents
drug therapy: Arthritis, Rheumatoid
Human
epidemiology: Lymphoma
Risk Factors
Support, Non-U.S. Gov't
antagonists & inhibitors: Tumor Necrosis Factor

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{72127a3d5c8d475b89d3081847338a22,

title = "Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.",

keywords = "adverse effects: Antirheumatic Agents, drug therapy: Arthritis, Rheumatoid, Human, epidemiology: Lymphoma, Risk Factors, Support, Non-U.S. Gov't, antagonists & inhibitors: Tumor Necrosis Factor",

author = "D Symmons and AJ. Silman",

year = "2004",

month = jun,

language = "English",

volume = "50( 6)",

journal = "Arthritis Rheum",

issn = "1529-0131",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.

AU - Symmons, D

AU - Silman, AJ.

PY - 2004/6

Y1 - 2004/6

KW - adverse effects: Antirheumatic Agents

KW - drug therapy: Arthritis, Rheumatoid

KW - Human

KW - epidemiology: Lymphoma

KW - Risk Factors

KW - Support, Non-U.S. Gov't

KW - antagonists & inhibitors: Tumor Necrosis Factor

M3 - Article

SN - 1529-0131

VL - 50( 6)

JO - Arthritis Rheum

JF - Arthritis Rheum

ER -